BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2015 5:11:00 PM | Browse: 1217 | Download: 1988
 |
Received |
|
2014-11-20 09:13 |
|
Peer-Review Started |
|
2014-11-20 15:41 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-12-25 17:25 |
|
Revised |
|
2015-03-17 00:00 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-07-15 17:23 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2015-07-23 16:54 |
|
Articles in Press |
|
2015-07-23 16:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-08-20 11:16 |
|
Publish the Manuscript Online |
|
2015-08-29 17:10 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Alissa Naqvi, Valérie Giordanengo, Brigitte Dunais, Francine de Salvador-Guillouet, Isabelle Perbost, Jacques Durant, Pascal Pugliese, Aline Joulié, Pierre Marie Roger and Eric Rosenthal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Eric Rosenthal, Professor, Internal Medicine Department, Archet Hospital, Centre Hospitalier Universitaire, 51 Route de Saint-Antoine, 06200 Nice,
France. rosenthal.e@chu-nice.fr
|
| Key Words |
Telaprevir; Boceprevir; Hepatitis C virus-human immunodeficiency virus coinfection; Resistance mutations |
| Core Tip |
Data regarding treatment of hepatitis C virus (HCV) infection with triple combination regimen including interferon/ribavirin and a protease inhibitor (telaprevir or boceprevir) among difficult to treat human immunodeficiency virus (HIV)-HCV co-infected patients are lacking. Most of the patients included in this single-center observational study had already failed a previous dual treatment course and had severe liver fibrosis, one out of six being both cirrhotic and non-responder to prior therapy. More than one of two patients displayed sustained virological response, suggesting that in low-income countries, telaprevir and boceprevir may retain their place among potential treatment strategies in HIV-HCV coinfected patients.
|
| Publish Date |
2015-08-29 17:10 |
| Citation |
Naqvi A, Giordanengo V, Dunais B, de Salvador-Guillouet F, Perbost I, Durant J, Pugliese P, Joulié A, Roger PM, Rosenthal E. Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection. World J Hepatol 2015; 7(18): 2177-2183
|
| URL |
http://www.wjgnet.com/1948-5182/full/v7/i18/2177.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v7.i18.2177 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
